These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27466407)

  • 1. Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β.
    Yim KH; Prince TL; Qu S; Bai F; Jennings PA; Onuchic JN; Theodorakis EA; Neckers L
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):E4801-9. PubMed ID: 27466407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90).
    Mak OW; Chand R; Reynisson J; Leung IKH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
    PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
    Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
    FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast.
    Synoradzki K; Bieganowski P
    Biochim Biophys Acta; 2015 Feb; 1853(2):445-52. PubMed ID: 25486457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the middle domains stabilizes Hsp90α dimer in a closed conformation with high affinity for p23.
    Synoradzki K; Miszta P; Kazlauskas E; Mickevičiūtė A; Michailovienė V; Matulis D; Filipek S; Bieganowski P
    Biol Chem; 2018 Mar; 399(4):337-345. PubMed ID: 29337688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.
    Zheng ZG; Zhang X; Liu XX; Jin XX; Dai L; Cheng HM; Jing D; Thu PM; Zhang M; Li H; Zhu J; Liu C; Xue B; Li Y; Chen L; Peng C; Zhu W; Wang L; Liu J; Li HJ; Li P; Xu X
    Theranostics; 2019; 9(20):5769-5783. PubMed ID: 31534518
    [No Abstract]   [Full Text] [Related]  

  • 8. The Noncompetitive Effect of Gambogic Acid Displaces Fluorescence-Labeled ATP but Requires ATP for Binding to Hsp90/HtpG.
    Yue Q; Stahl F; Plettenburg O; Kirschning A; Warnecke A; Zeilinger C
    Biochemistry; 2018 May; 57(18):2601-2605. PubMed ID: 29664615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of Hsp90α and Hsp90β bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity.
    Huck JD; Que NLS; Sharma S; Taldone T; Chiosis G; Gewirth DT
    Proteins; 2019 Oct; 87(10):869-877. PubMed ID: 31141217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90alpha/beta.
    Millson SH; Prodromou C; Piper PW
    Biochem Pharmacol; 2010 Jun; 79(11):1581-8. PubMed ID: 20138026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance.
    Maiti S; Picard D
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β.
    Petrenko V; Vrublevskaya V; Bystrova M; Masulis I; Kopylova E; Skarga Y; Zhmurina M; Morenkov O
    Biochem Biophys Res Commun; 2023 Sep; 674():62-68. PubMed ID: 37406487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
    McDowell CL; Bryan Sutton R; Obermann WM
    Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells.
    Houlihan JL; Metzler JJ; Blum JS
    J Immunol; 2009 Jun; 182(12):7451-8. PubMed ID: 19494268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta.
    Kobayakawa T; Yamada S; Mizuno A; Nemoto TK
    Cell Stress Chaperones; 2008; 13(1):97-104. PubMed ID: 18347946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep.
    Chang C; Tang X; Woodley DT; Chen M; Li W
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.
    Patel PD; Yan P; Seidler PM; Patel HJ; Sun W; Yang C; Que NS; Taldone T; Finotti P; Stephani RA; Gewirth DT; Chiosis G
    Nat Chem Biol; 2013 Nov; 9(11):677-84. PubMed ID: 23995768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor.
    Khandelwal A; Kent CN; Balch M; Peng S; Mishra SJ; Deng J; Day VW; Liu W; Subramanian C; Cohen M; Holzbeierlein JM; Matts R; Blagg BSJ
    Nat Commun; 2018 Jan; 9(1):425. PubMed ID: 29382832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles of molecular chaperones HSP90α and HSP90β in the biogenesis of KCNQ4 channels.
    Gao Y; Yechikov S; Vazquez AE; Chen D; Nie L
    PLoS One; 2013; 8(2):e57282. PubMed ID: 23431407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity.
    Chadli A; Felts SJ; Toft DO
    J Biol Chem; 2008 Apr; 283(15):9509-12. PubMed ID: 18285346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.